Short communication · 16 Sep 2020
Case reportPublished 2017
Impervious Coronary No-Reflow: A Case Study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Coronary no-reflow phenomenon is a disorder of the microvasculature that results in poor myocardial perfusion in patients with acute myocardial infarction receiving percutaneous coronary intervention. It typically manifests as TIMI 1-2 flow, high TIMI frame counts, and abnormal myocardial blush. The etiology of this condition is multifactorial and so is its treatment. It is encountered in approximately one-third of patients and is therefore of clinical relevance. In this case report, we describe a patient scenario with this condition in which the standard therapy was provided but failed to achieve normal perfusion despite repeat attempts. We also discuss different pharmacological therapies that compose the standard therapy and other adjunctive remedies that have been proven to be beneficial.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 26 Oct 2015
Effects of Thrombus Aspiration Catheter Combined with Atorvastatin in Reducing No-Reflow Phenomenon in Emergency Percutaneous Coronary Intervention for Acute Myocardial Infarction
Conference abstract · 2018
Predictors of no-reflow in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Review article · 21 Jul 2016
Primary percutaneous coronary intervention: devices to prevent no-reflow phenomenon
Review article · 20 Jul 2016
Managing no-reflow during percutaneous coronary intervention
More from this journal
The newest in Cardiovascular Pharmacology: Open Access.
Article · 28 Jun 2025
Advances in Antiplatelet Therapy for Secondary Prevention of Myocardial Infarction
Article · 28 Jun 2025
Beta Blockers and Their Expanding Role in Cardiovascular Disease
Article · 28 Jun 2025
Emerging Role of PCSK9 Inhibitors in Lipid Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- SubjectCardiology
- BylineArticles whose byline prints “Karimianpour A”
- BylineArticles whose byline prints “Maran A”

